期刊文献+

受胆固醇调节的变异剪接体及其意义

Cholesterol-regulated Variant Spliceosomes and Their Significance
下载PDF
导出
摘要 目的:检测人肝癌细胞中LDLR的变异剪接体LDLR-?Exon4、LDLR-?Exon12,HMGCS1的变异剪接体HMGCS1-?Exon2和HMGCR的变异剪接体HMGCR-Exon?13是否受胆固醇的调节。方法:建立高胆固醇模型组、低胆固醇模型组及正常组,提取不同模型组的RNA并进行反转录,采用Realtime PCR(RT-PCR)技术检测LDLR-?Exon4,LDLR-?Exon12,HMGCS1-?Exon2和HMGCR-Exon?13的mRNA的表达。结果:在高胆固醇模型组中,与正常组相比,LDLR-?Exon4、LDLR-?Exon12、HMGCS1-?Exon2及HMGCR-Exon?13的mRNA的表达量与各基因全长相比均明显升高(P<0.05);而在低胆固醇模型组中,与正常组相比,上述的变异剪接体mRNA的表达量与各基因全长相比均明显下降(P<0.05)。结论:LDLR-?Exon4、LDLR-?Exon12、HMGCS1-?Exon2及HMGCR-Exon?13等变异剪接体受胆固醇的调节,并可能参与并调控胆固醇的代谢。 Objective:To detect whether LDLR,HMGCS1 and HMGCR alternatively spliced variants LDLR-ΔExon4,LDLR-ΔExon12,HMGCS1-ΔExon2 and HMGCR-ΔExon13 regulated by cholesterol in human hepatocellular carcinoma cells.Method:The high cholesterol model group and the low cholesterol model group were established,and compared with the normal group.RNA extraction of different model cells was reverse transcribed,and Real-time PCR(RT-PCR)technology was used to detect mRNA expression of LDLR-ΔExon4,LDLR-ΔExon12,HMGCS1-ΔExon2 and HMGCR-ΔExon13.Result:Compared with the normal group,mRNA expression of LDLR-ΔExon4,LDLR-ΔExon12,HMGCS1-ΔExon2 and HMGCR-ΔExon13 were increased in the high cholesterol model group(P<0.05).However,mRNA expression of LDLR-ΔExon4,LDLR-ΔExon12,HMGCS1-ΔExon2 and HMGCR-ΔExon13 were decreased in the low cholesterol model group compared with the normal group(P<0.05).Conclusion:LDLR-ΔExon4,LDLR-ΔExon12,HMGCS1-ΔExon2 and HMGCR-ΔExon13 spliced variants are regulated by cholesterol and may participate in regulating the metabolism of cholesterol.
作者 庞亚娜 赵晋枫 董元坤 张策 PANG Yana;ZHAO Jinfeng;DONG Yuankun;ZHANG Ce(Shanxi Medical University,Taiyuan 030001,China)
出处 《中国医学创新》 CAS 2018年第8期18-22,共5页 Medical Innovation of China
基金 国家青年科学基金项目(31500962)
关键词 选择性剪接 胆固醇 变异剪接体 Alternative splicing Cholesterol Spliced variants
  • 相关文献

参考文献2

二级参考文献85

  • 1Chen HW, Leonard DA, Fischer RT, Trzaskos JM. A mammalian mutant cell lacking detectable lanosterol 14 alpha-methyl demethylase activity. J Biol Chem 1988; 263:1248-1254.
  • 2Leonard DA, Kotarski MA, Tessiatore JE, Favata MF, Trzaskos JM. Post-transcriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase by 3 beta-hydroxy-lanost-8-en-32-al, an intermediate in the conversion of lanosterol to cholesterol. Arch Biochem Biophys 1994; 310:152-157.
  • 3Song BL, Javitt NB, DeBose-Boyd RA. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol. Cell Metabolism 2005; 1:179-189.
  • 4Gaylor JL. Membrane-bound enzymes of cholesterol synthesis from Lanosterol. Biochem Biophys Res Commun 2002; 292:1139- 1146.
  • 5Williams MT, Gaylor JL, Morris HP. Investigation of the ratedetermining microsomal reaction of cholesterol biosynthesis from lanosterol in Morris hepatomas and liver. CancerRes 1977; 37:1377-1383.
  • 6Xu F, Rychnovsky SD, Belani JD, et al. Dual roles for cholesterol in mammalian cells. Proc Natl Acad Sci USA 2005; 102:14551- 14556.
  • 7Nguyen AD, McDonald JG, Bruick RK, DeBose-Boyd RA. Hypoxia stimulates degradation of 3-hydroxy-3-methylglutaryl- coenzyme A reductase through accumulation of lanosterol and hypoxia-inducible factor-mediated induction of insigs. J Biol Chem 2007; 282:27436-27446.
  • 8Maxwell PH, Wiesener MS, Chang GW, et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399:271-275.
  • 9Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107:43-54.
  • 10Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001; 294:1337-1340.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部